Target intelligence / Profile preview

Alloantigen

Molecular classification
Other (category: polymorphic antigens; examples include "histocompatibility antigen", "blood group antigen")
01

Overview

Alloantigens are antigens present in some but not all members of a species, arising from genetic differences between individuals. They trigger immune responses when there is exposure to non-self antigens from the same species, as during transplantation, transfusion, or pregnancy[1][3][5]. Two major classes of alloantigens include blood group antigens and histocompatibility antigens (such as the major histocompatibility complex, or HLA, in humans)[1][3]. The immune response to alloantigens is the basis for graft rejection and transfusion reactions, mediated by direct, indirect, or semidirect pathways of T cell and antibody recognition[2][4][7]. Alloantigen is not an actionable single molecular target but encompasses a range of antigens differing between individuals, most notably in transfusion and transplantation medicine[1][3][5].

Other names
allogeneic antigenisoantigen
02

Biological functions

Immune responseGraft rejectionTransfusion reaction
03

Disease associations

Organ transplantation rejectionBlood transfusion reactionHemolytic disease of the newborn

Beyond the preview

Go deeper on Alloantigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alloantigen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call